vs
Foghorn Therapeutics Inc.（FHTX）与Valaris Ltd（VAL）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是Valaris Ltd的1.8倍（$9.2M vs $5.2M），Valaris Ltd净利率更高（13798.1% vs -234.3%，领先14032.4%），Valaris Ltd同比增速更快（405.9% vs 223.8%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 29.5%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
瓦拉瑞斯有限公司是全球领先的海上钻井承包商，总部位于美国得克萨斯州休斯敦，注册地为百慕大，是全球规模最大的海上钻井及油井钻井服务企业。截至2025年2月，公司共运营52座钻井平台，包含36座海上自升式钻井平台、11艘钻井船以及5座半潜式钻井平台。
FHTX vs VAL — 直观对比
营收规模更大
FHTX
是对方的1.8倍
$5.2M
营收增速更快
VAL
高出182.1%
223.8%
净利率更高
VAL
高出14032.4%
-234.3%
两年增速更快
FHTX
近两年复合增速
29.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $5.2M |
| 净利润 | $-21.7M | $717.5M |
| 毛利率 | — | -7850.0% |
| 营业利润率 | -258.2% | — |
| 净利率 | -234.3% | 13798.1% |
| 营收同比 | 223.8% | 405.9% |
| 净利润同比 | -11.1% | 436.6% |
| 每股收益（稀释后） | $-0.35 | $10.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXVAL
| Q4 25 | $9.2M | $5.2M | ||
| Q3 25 | $8.2M | $5.6M | ||
| Q2 25 | $7.6M | $700.0K | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $2.9M | $-1.7M | ||
| Q3 24 | $7.8M | $3.9M | ||
| Q2 24 | $6.9M | $4.8M | ||
| Q1 24 | $5.0M | $2.6M |
净利润FHTXVAL
| Q4 25 | $-21.7M | $717.5M | ||
| Q3 25 | $-15.8M | $188.1M | ||
| Q2 25 | $-17.9M | $115.1M | ||
| Q1 25 | $-18.8M | — | ||
| Q4 24 | $-19.5M | $133.7M | ||
| Q3 24 | $-19.1M | $64.6M | ||
| Q2 24 | $-23.0M | $149.6M | ||
| Q1 24 | $-25.0M | $25.5M |
毛利率FHTXVAL
| Q4 25 | — | -7850.0% | ||
| Q3 25 | — | -7142.9% | ||
| Q2 25 | — | -56428.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 24529.4% | ||
| Q3 24 | — | -11748.7% | ||
| Q2 24 | — | -9039.6% | ||
| Q1 24 | — | -17007.7% |
营业利润率FHTXVAL
| Q4 25 | -258.2% | — | ||
| Q3 25 | -226.9% | — | ||
| Q2 25 | -279.2% | — | ||
| Q1 25 | -385.0% | — | ||
| Q4 24 | -840.5% | — | ||
| Q3 24 | -305.5% | — | ||
| Q2 24 | -386.6% | — | ||
| Q1 24 | -558.3% | — |
净利率FHTXVAL
| Q4 25 | -234.3% | 13798.1% | ||
| Q3 25 | -194.4% | 3358.9% | ||
| Q2 25 | -237.3% | 16442.9% | ||
| Q1 25 | -316.4% | — | ||
| Q4 24 | -682.9% | -7864.7% | ||
| Q3 24 | -244.9% | 1656.4% | ||
| Q2 24 | -333.6% | 3116.7% | ||
| Q1 24 | -495.4% | 980.8% |
每股收益（稀释后）FHTXVAL
| Q4 25 | $-0.35 | $10.13 | ||
| Q3 25 | $-0.25 | $2.65 | ||
| Q2 25 | $-0.28 | $1.61 | ||
| Q1 25 | $-0.30 | — | ||
| Q4 24 | $-0.23 | $1.86 | ||
| Q3 24 | $-0.31 | $0.88 | ||
| Q2 24 | $-0.45 | $2.03 | ||
| Q1 24 | $-0.59 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $599.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $3.2B |
| 总资产 | $198.1M | $5.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXVAL
| Q4 25 | $80.9M | $599.4M | ||
| Q3 25 | $89.3M | $662.7M | ||
| Q2 25 | $72.6M | $503.4M | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | $368.2M | ||
| Q3 24 | $57.7M | $379.3M | ||
| Q2 24 | $138.9M | $398.3M | ||
| Q1 24 | $79.3M | $494.1M |
股东权益FHTXVAL
| Q4 25 | $-108.5M | $3.2B | ||
| Q3 25 | $-89.7M | $2.4B | ||
| Q2 25 | $-76.7M | $2.3B | ||
| Q1 25 | $-61.7M | — | ||
| Q4 24 | $-45.5M | $2.2B | ||
| Q3 24 | $-28.3M | $2.1B | ||
| Q2 24 | $-14.3M | $2.2B | ||
| Q1 24 | $-97.5M | $2.0B |
总资产FHTXVAL
| Q4 25 | $198.1M | $5.3B | ||
| Q3 25 | $205.0M | $4.6B | ||
| Q2 25 | $226.2M | $4.5B | ||
| Q1 25 | $258.7M | — | ||
| Q4 24 | $284.0M | $4.4B | ||
| Q3 24 | $308.4M | $4.3B | ||
| Q2 24 | $328.6M | $4.4B | ||
| Q1 24 | $255.0M | $4.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $72.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-34.1M |
| 自由现金流率自由现金流/营收 | — | -655.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2044.2% |
| 现金转化率经营现金流/净利润 | — | 0.10× |
| 过去12个月自由现金流最近4个季度 | — | $159.9M |
8季度趋势，按日历期对齐
经营现金流FHTXVAL
| Q4 25 | $-22.3M | $72.2M | ||
| Q3 25 | $-18.9M | $198.1M | ||
| Q2 25 | $-21.0M | $120.0M | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-24.5M | $124.6M | ||
| Q3 24 | $-21.0M | $193.0M | ||
| Q2 24 | $-25.5M | $11.5M | ||
| Q1 24 | $-29.3M | $26.3M |
自由现金流FHTXVAL
| Q4 25 | — | $-34.1M | ||
| Q3 25 | — | $128.3M | ||
| Q2 25 | $-21.0M | $52.8M | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | $12.9M | ||
| Q3 24 | $-21.3M | $111.1M | ||
| Q2 24 | $-25.6M | $-98.7M | ||
| Q1 24 | $-29.4M | $-125.0M |
自由现金流率FHTXVAL
| Q4 25 | — | -655.8% | ||
| Q3 25 | — | 2291.1% | ||
| Q2 25 | -278.2% | 7542.9% | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | -758.8% | ||
| Q3 24 | -273.0% | 2848.7% | ||
| Q2 24 | -371.0% | -2056.3% | ||
| Q1 24 | -583.1% | -4807.7% |
资本支出强度FHTXVAL
| Q4 25 | 0.0% | 2044.2% | ||
| Q3 25 | 0.0% | 1246.4% | ||
| Q2 25 | 0.3% | 9600.0% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | -6570.6% | ||
| Q3 24 | 4.0% | 2100.0% | ||
| Q2 24 | 0.2% | 2295.8% | ||
| Q1 24 | 2.0% | 5819.2% |
现金转化率FHTXVAL
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
